{"transactions":[{"id":4629992,"issuer":{"id":5215,"kind":"organization","name":"BridgeBio Oncology Therapeutics, Inc.","symbol":"BBOT"},"owners":[{"id":32182,"kind":"person","name":"Elmelech Idan","position":1,"cik":"0002058437","reported_name":"Elmelech Idan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & Principal Financial Ofcr"}}],"security":"Common Stock","published_at":"2026-10-05T20:13:56.000Z","date":"2026-10-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":343,"price":3.94,"value":1351.42,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of the Issuer's Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":14152,"source":{"system":"sec-edgar","filing":"0001193125-26-414131","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2058437/000119312526414131/ownership.xml","form_type":"4"}},{"id":715544,"issuer":{"id":5215,"kind":"organization","name":"BridgeBio Oncology Therapeutics, Inc.","symbol":"BBOT"},"owners":[{"id":32182,"kind":"person","name":"Elmelech Idan","position":1,"cik":"0002058437","reported_name":"Elmelech Idan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & Principal Financial Ofcr"}}],"security":"Common Stock","published_at":"2026-07-06T22:00:06.000Z","date":"2026-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":343,"price":7.8,"value":2675.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of the Issuer's Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":14495,"source":{"system":"sec-edgar","filing":"0001193125-26-296503","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526296503/ownership.xml","form_type":"4"}},{"id":782679,"issuer":{"id":5215,"kind":"organization","name":"BridgeBio Oncology Therapeutics, Inc.","symbol":"BBOT"},"owners":[{"id":32182,"kind":"person","name":"Elmelech Idan","position":1,"cik":"0002058437","reported_name":"Elmelech Idan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & Principal Financial Ofcr"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-12T20:12:24.000Z","date":"2026-05-10","kind":"grant","planned":false,"acquired":true,"shares":758222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of April 20, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":758222,"derivative":{"exercise_price":7.66,"expiration_date":"2036-05-09","underlying":"Common Stock","underlying_shares":758222},"source":{"system":"sec-edgar","filing":"0001193125-26-219447","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526219447/ownership.xml","form_type":"4"}}]}